(Q36944293)

English

Expression of the Wnt antagonist Dickkopf-3 is associated with prognostic clinicopathologic characteristics and impairs proliferation and invasion in endometrial cancer

scientific article published on 30 April 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

17 August 2017

Expression of the Wnt antagonist Dickkopf-3 is associated with prognostic clinicopathologic characteristics and impairs proliferation and invasion in endometrial cancer (English)

1 reference

Europe PubMed Central

17 August 2017

Bradley J. Monk

7

object named as

Bradley J Monk

1 reference

Europe PubMed Central

17 August 2017

author name string

Thanh H Dellinger

1

1 reference

Europe PubMed Central

17 August 2017

Kestutis Planutis

2

1 reference

Europe PubMed Central

17 August 2017

Danielle D Jandial

3

1 reference

Europe PubMed Central

17 August 2017

Ramez N Eskander

4

1 reference

Europe PubMed Central

17 August 2017

Micaela E Martinez

5

1 reference

Europe PubMed Central

17 August 2017

Xiaolin Zi

6

1 reference

Europe PubMed Central

17 August 2017

Randall F Holcombe

8

1 reference

Europe PubMed Central

17 August 2017

language of work or name

0 references

publication date

30 April 2012

1 reference

Europe PubMed Central

17 August 2017

Gynecologic Oncology

1 reference

Europe PubMed Central

17 August 2017

126

1 reference

Europe PubMed Central

17 August 2017

2

1 reference

Europe PubMed Central

17 August 2017

259-267

1 reference

Europe PubMed Central

17 August 2017

Role of canonical Wnt signaling in endometrial carcinogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688285

29 September 2017

Targeting the Wnt pathway in cancer: the emerging role of Dickkopf-3.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688285

29 September 2017

Phase II study of temsirolimus in women with recurrent or metastatic endometrial cancer: a trial of the NCIC Clinical Trials Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688285

29 September 2017

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688285

29 September 2017

Phase II trial of bevacizumab in recurrent or persistent endometrial cancer: a Gynecologic Oncology Group study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688285

29 September 2017

Methylation of Dickkopf-3 as a prognostic factor in cirrhosis-related hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688285

29 September 2017

REIC/Dkk-3 stable transfection reduces the malignant phenotype of mouse prostate cancer RM9 cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688285

29 September 2017

Genomic screening for genes upregulated by demethylation revealed novel targets of epigenetic silencing in breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688285

29 September 2017

Dickkopf-1 autoantibody is a novel serological biomarker for non-small cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688285

29 September 2017

Systemic therapy for recurrent endometrial cancer: a review of North American trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688285

29 September 2017

Promoter methylation and mRNA expression of DKK-3 and WIF-1 in hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688285

29 September 2017

Dkk-3 expression in the tumor endothelium: a novel prognostic marker of pancreatic adenocarcinomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688285

29 September 2017

Novel expression profiles and invasiveness-related biology function of DKK1 in endometrial carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688285

29 September 2017

Overexpression of REIC/Dkk-3 in normal fibroblasts suppresses tumor growth via induction of interleukin-7

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688285

29 September 2017

Promoter methylation of the Wnt/beta-catenin signaling antagonist Dkk-3 is associated with poor survival in gastric cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688285

29 September 2017

Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688285

29 September 2017

Secreted frizzled-related protein 4 regulates two Wnt7a signaling pathways and inhibits proliferation in endometrial cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688285

29 September 2017

Wnt signaling in ovarian tumorigenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688285

29 September 2017

Attenuation of WNT signaling by DKK-1 and -2 regulates BMP2-induced osteoblast differentiation and expression of OPG, RANKL and M-CSF

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688285

29 September 2017

Increased Dickkopf-1 expression in breast cancer bone metastases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688285

29 September 2017

Adenovirus-mediated REIC/Dkk-3 gene transfer inhibits tumor growth and metastasis in an orthotopic prostate cancer model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688285

29 September 2017

Blocking Wnt/LRP5 signaling by a soluble receptor modulates the epithelial to mesenchymal transition and suppresses met and metalloproteinases in osteosarcoma Saos-2 cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688285

29 September 2017

REIC/Dkk-3 as a potential gene therapeutic agent against human testicular cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688285

29 September 2017

Chemotherapy in endometrial cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688285

29 September 2017

ECC-1 cells: a well-differentiated steroid-responsive endometrial cell line with characteristics of luminal epithelium

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688285

29 September 2017

Generation and characterization of dickkopf3 mutant mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688285

29 September 2017

Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688285

29 September 2017

Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688285

29 September 2017

Expression of Frzb/secreted Frizzled-related protein 3, a secreted Wnt antagonist, in human androgen-independent prostate cancer PC-3 cells suppresses tumor growth and cellular invasiveness

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688285

29 September 2017

Adenovirus-mediated overexpression of REIC/Dkk-3 selectively induces apoptosis in human prostate cancer cells through activation of c-Jun-NH2-kinase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688285

29 September 2017

Functional epigenomics identifies genes frequently silenced in prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688285

29 September 2017

Dickkopf-3/REIC functions as a suppressor gene of tumor growth

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688285

29 September 2017

Dickkopf 3 inhibits invasion and motility of Saos-2 osteosarcoma cells by modulating the Wnt-beta-catenin pathway

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688285

29 September 2017

Decreased expression of REIC/Dkk-3 in human renal clear cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688285

29 September 2017

A novel immortalized human endometrial stromal cell line with normal progestational response

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688285

29 September 2017

Caught up in a Wnt storm: Wnt signaling in cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688285

29 September 2017

The Ishikawa Cells from Birth to the Present

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688285

29 September 2017

Reduced expression of the REIC/Dkk-3 gene by promoter-hypermethylation in human tumor cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688285

29 September 2017

beta- Catenin mutations and aberrant nuclear expression during endometrial tumorigenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688285

29 September 2017

A REIC gene shows down-regulation in human immortalized cells and human tumor-derived cell lines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688285

29 September 2017

Two pathogenetic types of endometrial carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688285

29 September 2017

Genetic alterations during colorectal-tumor development

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688285

29 September 2017

Downregulation of Dkk3 activates beta-catenin/TCF-4 signaling in lung cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688285

4 September 2018

Nuclear beta-catenin is a molecular feature of type I endometrial carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688285

4 September 2018

Abnormalities of the APC/beta-catenin pathway in endometrial cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688285

4 September 2018

Mutation of beta-catenin gene in endometrial cancer but not in associated hyperplasia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688285

4 September 2018

Adenocarcinoma of the endometrium: its metastatic lymph node potential. A preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.04.026

7 January 2021

Frequent nuclear beta-catenin accumulation and associated mutations in endometrioid-type endometrial and ovarian carcinomas with squamous differentiation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.04.026

7 January 2021

CTNNB1 mutations and beta-catenin expression in endometrial carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.04.026

7 January 2021

Nuclear localization of beta-catenin in normal and carcinogenic endometrium

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.04.026

7 January 2021

Mutational analysis of the CTNNB1 and APC genes in uterine endometrioid carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.04.026

7 January 2021

Clinical significance of serum DKK-1 in patients with gynecological cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.04.026

7 January 2021

Dkk3, downregulated in cervical cancer, functions as a negative regulator of beta-catenin

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.04.026

7 January 2021

REIC/Dkk-3 overexpression downregulates P-glycoprotein in multidrug-resistant MCF7/ADR cells and induces apoptosis in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.04.026

7 January 2021

Clinical significance of serum Dkk-3 in patients with gynecological cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.04.026

7 January 2021

Functional significance of Wnt inhibitory factor-1 gene in kidney cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.04.026

7 January 2021

Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.04.026

7 January 2021

A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.04.026

7 January 2021

Antiproliferative activity of REIC/Dkk-3 and its significant down-regulation in non-small-cell lung carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.04.026

7 January 2021

Mutational analysis of the CTNNB1 (beta-catenin) gene in human endometrial cancer: frequent mutations at codon 34 that cause nuclear accumulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/22555103

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced expression of REIC/Dkk-3 gene in non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22555103

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beta-catenin mutation in carcinoma of the uterine endometrium

1 reference

https://pubmed.ncbi.nlm.nih.gov/22555103

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beta-catenin mutations are specific for colorectal carcinomas with microsatellite instability but occur in endometrial carcinomas irrespective of mutator pathway

1 reference

https://pubmed.ncbi.nlm.nih.gov/22555103

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.YGYNO.2012.04.026

1 reference

Europe PubMed Central

17 August 2017

1 reference

Europe PubMed Central

17 August 2017

1 reference

Europe PubMed Central

17 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36944293&oldid=2032769599"